Mkts

Bionano Genomics, Inc.

NASDAQ: BNGO
$0.88+0.00 (-0.56%)
As of Nov 20, 9:30 AM ET

Key statistics

Day range
0.880.90
52-week range
0.872.23
Today
Open0.89
Previous close0.88
Volume33.5K
Valuation
Market cap13.66M
P/E ratio—
EPS (TTM)-3.76
Income & risk
Dividend / yield—
Beta1.80
Avg volume338.1K
Discussion

BNGO News

Stories mentioning BNGO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue6,6877,9517,3676,7336,4578,1636,0737,771
Cost of Goods Sold3,4354,5513,9973,2563,5194,74614,5195,186
Gross Profit3,2523,4003,3703,4772,9383,417(8,446)2,585
Operating Expenses
Research & Development3,1393,2292,8442,9312,3703,4764,7176,831
Sales General & Admin8,0108,7079,0648,3469,03311,7469,46411,557
Total Operating Expenses
Operating Income (Loss)(7,897)(8,536)(8,538)(7,800)(8,465)(11,941)(43,901)(17,018)
Interest Income
Interest Expense
Other Expense(619.00)363.00(219.00)676.005,080(8,407)(697.00)363.00
Pretax Income(8,293)(7,897)(8,489)(6,847)(3,095)(20,124)(44,222)(16,198)
Tax Provision10.0036.0014.0010.007.001.0024.0026.00
Net Income (Loss)(8,303)(7,933)(8,503)(6,857)(3,102)(20,125)(44,246)(16,224)
Earnings Per Share (Basic)(0.76)(1.46)(1.59)(1.99)(1.15)(15.83)(30.92)(14.41)
Earnings Per Share (Diluted)(0.76)(1.46)(1.59)(1.99)(1.15)(15.83)(30.92)(14.41)
Weighted Average Shares Outstanding (Basic)10,9795,4455,3383,4412,6941,2711,4311,126
Weighted Average Shares Outstanding (Diluted)10,9795,4455,3383,4412,6941,2711,4311,126

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BNGO

Bionano Genomics, Inc. (NASDAQ: BNGO) is a stock listed on the Nasdaq Stock Market under the ticker symbol BNGO. It last traded at $0.8800 (Nov 20, 2026, 9:30 AM ET), down 0.6% on the day. That gives Bionano Genomics a market capitalisation of $13.7M.

Over the past 52 weeks BNGO has traded between $0.8700 and $2.23.

Revenue for the quarter ended Mar 31, 2026 was $6.7M; a net loss of $8.3M. Revenue was up 3.6% from $6.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$6.7M-$8.3M-124.2%
Dec 31, 2025$8.0M-$7.9M-99.8%
Sep 30, 2025$7.4M-$8.5M-115.4%
Jun 30, 2025$6.7M-$6.9M-101.8%

From Bionano Genomics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…